Clinical Trial Update: Study in Subjects With Mild-to-Moderate Alzheimer's Dementia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial in mild-to-moderate Alzheimer's disease is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Alzamend Neuro, Inc. | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING